Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Amicus Therapeutics (FOLD) Tax Rate (2016 - 2025)

Amicus Therapeutics filings provide 10 years of Tax Rate readings, the most recent being 46.23% for Q4 2025.

  • On a quarterly basis, Tax Rate rose 13200.0% to 46.23% in Q4 2025 year-over-year; TTM through Dec 2025 was 14293.72%, a 1438883.0% increase, with the full-year FY2025 number at 14293.72%, up 1438883.0% from a year prior.
  • Tax Rate hit 46.23% in Q4 2025 for Amicus Therapeutics, down from 49.51% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 14634.26% in Q2 2024 to a low of 85.77% in Q4 2024.
  • Median Tax Rate over the past 5 years was 3.09% (2021), compared with a mean of 738.46%.
  • Biggest five-year swings in Tax Rate: skyrocketed 1464096bps in 2024 and later tumbled -1466157bps in 2025.
  • Amicus Therapeutics' Tax Rate stood at 3.71% in 2021, then skyrocketed by 646bps to 20.28% in 2022, then plummeted by -134bps to 6.9% in 2023, then tumbled by -1144bps to 85.77% in 2024, then surged by 154bps to 46.23% in 2025.
  • The last three reported values for Tax Rate were 46.23% (Q4 2025), 49.51% (Q3 2025), and 27.31% (Q2 2025) per Business Quant data.